Stock futures have been bouncing around in the pre-market as investors await some big economic data on June 1.

The week of June 1 will be hectic will tons of stock market-moving economic data and plenty of earnings reports.

Investors are looking for a “V” or “U” shaped recovery, but it just may not be possible to recover that quickly.

It has become clear that brokers-dealers need to get long the S&P 500 at 3000 and short at 3050, for now at least.

Stocks are bouncing around on May 29 ahead of an important announcement on China and next week’s data dump.

The momentum trade driving stocks higher may be very close to breaking.

Stocks are trying to rally on May 28, but are struggling despite yesterday’s big rebound.

It was a wild day on May 27 for stocks, with what seems to be bizarre price action in a very strange stock market.

Stocks will try to rise again on May 27 as fresh stimulus plans from the EU help.

Stocks managed to finish the day higher on May 26, but struggled to finish out the day as China headlines made the rounds.

Stocks are rising on May 26 as the global rally pushes forward, and markets look out to the year 2022.

Earnings estimates for 2020 and 2021 continue to fall, and that doesn’t paint a rosy outlook for the stock market.

The week of May 25 will be a holiday-shortened one, but that doesn’t mean it won’t be a busy one. Here are eight stocks to watch for the week.

Stocks are trying to bounce back on May 22 after falling yesterday.

Stocks fell on May 21 as some key technology stocks broke significant uptrends.

Stocks are pointing to a lower start on May 21 ahead of what is likely to be a busy day for economic data.

Stocks jumped today, bouncing back from yesterday’s steep afternoon plunge. The bulls continue to run, trampling all that stand in their way.

The market turned sharply lower in the middle of the afternoon in an odd turn of events as more warnings mount.

Stocks futures were high, then lower, now flat. Regardless it should be another fun day.

Stocks rise on Monday on hopes of a coronavirus vaccine, but despite the significant gains, there was nothing too impressive.